SiriusPoint Ltd removes Series B preference shares from NYSE

SiriusPoint Ltd has had its 8.00% Resettable Fixed Rate Preference Shares, Series B removed from listing and registration on the New York Stock Exchange LLC.

Rhea-AI Filing Summary

SiriusPoint Ltd has had its 8.00% Resettable Fixed Rate Preference Shares, Series B removed from listing and registration on the New York Stock Exchange LLC. The Exchange states it complied with Rule 17 CFR 240.12d2-2 and that the issuer complied with the Exchange's withdrawal requirements.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did SiriusPoint Ltd file with the SEC regarding SPNT preference shares?

The filing notifies removal of the 8.00% Resettable Fixed Rate Preference Shares, Series B from NYSE listing and registration. It states the Exchange and issuer complied with 17 CFR 240.12d2-2 procedures governing withdrawal.

Which securities were removed from the NYSE for SiriusPoint Ltd (SPNT)?

The securities removed were the 8.00% Resettable Fixed Rate Preference Shares, Series B with a $25.00 liquidation preference per share. The Form 25 identifies that specific class as the subject of the removal.

Who certified compliance for the removal of SPNT shares from listing?

The New York Stock Exchange LLC certified it had reasonable grounds to file Form 25 and that it complied with its rules under 17 CFR 240.12d2-2. The filing is signed by an NYSE representative, Tyler Mastronardi.

Does the Form 25 state whether the issuer approved the withdrawal?

Yes. The Form 25 states the issuer complied with the Exchange's rules and the requirements of 17 CFR 240.12d-2(c) governing voluntary withdrawal of the class of securities from listing and registration.

Where is SiriusPoint Ltd's principal executive office listed in the filing?

The filing lists SiriusPoint Ltd's principal executive office address as One World Trade Center, New York. A telephone number field appears but no phone number is provided in the excerpt.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 02/26/2026 - 10:07 AM Learn about SEC filing dates

UNITED STATES

OMB APPROVAL

OMB Number:			3235-0080
Expires:	March 31, 2018
Estimated average burden
hours per response:			1.7

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 25

NOTIFICATION OF REMOVAL FROM LISTING AND/OR REGISTRATION
UNDER SECTION 12(b) OF THE SECURITIES EXCHANGE ACT OF 1934.

Commission File Number

001-36052

Issuer:	SiriusPoint Ltd
Exchange:	NEW YORK STOCK EXCHANGE LLC

(Exact name of Issuer as specified in its charter, and name of Exchange where security is listed and/or registered)

Address:	ONE WORLD TRADE CENTER
		NEW YORK
Telephone number:

(Address, including zip code, and telephone number, including area code, of Issuer's principal executive offices)

8.00% Resettable Fixed Rate Preference Shares, Series B, $25.00 liquidation preference per share

(Description of class of securities)

Please place an X in the box to designate the rule provision relied upon to strike the class of securities from listing and registration:

17 CFR 240.12d2-2(a)(1)

17 CFR 240.12d2-2(a)(2)

17 CFR 240.12d2-2(a)(3)

17 CFR 240.12d2-2(a)(4)

Pursuant to 17 CFR 240.12d2-2(b), the Exchange has complied with its rules to strike the class of securities from listing and/or withdraw registration on the Exchange. ¹

Pursuant to 17 CFR 240.12d2-2(c), the Issuer has complied with its rules of the Exchange and the requirements of 17 CFR 240.12d-2(c) governing the voluntary withdrawal of the class of securities from listing and registration on the Exchange.

Pursuant to the requirements fo the Securities Exchange Act of 1934, NEW YORK STOCK EXCHANGE LLC certifies that it has reasonable grounds to believe that it meets all of the requirements for filing the Form 25 and has caused this notification to be signed on its behalf by the undersigned duly authorized person.

2026-02-26	By	Tyler Mastronardi		Analyst, Market Watch
Date		Name		Title

¹ Form 25 and attached Notice will be considered compliance with the provisions of 17 CFR 240.19d-1 as applicable. See General Instructions.

Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.